Patents
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
06/2010
06/16/2010CN1863805B Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof
06/15/2010US7737153 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
06/15/2010US7737126 agonist of adenosine A2A receptor; treatment of asthma and chronic obstructive pulmonary disease; example: (2R,3R,4S,5R,2'R,3'R,4'S,5'R)-2,2'-{trans-1,4-cyclohexanediylbis[imino(2-{[2-(1-methyl-1H-imidazol-4-yl)ethyl]amino}-9H-purine-6,9-diyl)]}bis[5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol]
06/15/2010US7736902 analyzing a solution containing enantiomorph such as such as a diamine or an amino alcohol, and a porphyrin dimer by circular dichroism spectroscopy
06/15/2010CA2383340C Thienoisoxazolyl- and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as d4 antagonists
06/15/2010CA2379103C Novel spiro compounds
06/10/2010WO2010063929A1 6-cycloamino-3-(1h-pyrrolo[2,3-b]pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof
06/10/2010US20100144703 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
06/10/2010CA2743560A1 6-cycloamino-3-(1h-pyrrolo[2,3-b]pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof
06/09/2010CN1894250B Substituted 8-heteroaryl xanthines
06/09/2010CN1880319B Tropane derivatives as CCR5 modulators
06/09/2010CN101723961A Beta-lactam twin antibiotic compound, preparation method thereof and use thereof
06/09/2010CN101723960A Benzopyran zofuran compound as well as preparation method and application thereof
06/09/2010CN101284842B Method for preparing vinorelbine tartrate with vinblastine sulfate
06/08/2010US7732507 Spirotetrathiocarbamates and spirooxothiocarbamates
06/08/2010US7732477 2-heteroarylcarboxylic acid amides
06/08/2010US7732455 Adenosine A2B receptor antagonists; asthma, allergies, allergic diseases or an autoimmune disease, diarrheal diseases, insulin resistance, diabetes, cancer, ischemia, reperfusion injuries, retinopathy; e.g. 1,3-Dipropyl-8-(6-chloro-3-pyridyl)xanthine
06/08/2010US7732437 Such as 3-[2-[4-(11,12-dihydro-6H-benzimidazo[2,1-b][3]benzazepin-6-yl)-2-(phenyl-methyl)-1-piperidinyl]ethyl]-2,10-dimethyl pyrimido[1,2- alpha ]benzimidazol-4(10H)-one
06/08/2010CA2433453C Triazolo[4,5-d]pyrimidine derivatives and their use as purinergic receptor antagonists
06/03/2010WO2009053715A8 Thienopyrimidiene derivatives as pi3k inhibitors
06/03/2010US20100137444 Ketone compounds and compositions for cholesterol management and related uses
06/03/2010US20100137283 Inhibitors of the hiv integrase enzyme
06/02/2010EP2102207B1 Spiro-piperidine derivatives as via receptor antagonists
06/02/2010CN101168732B Method for producing Vinca rosea alkaloid
06/01/2010US7728000 compounds which intercalate between DNA base pairs, resulting in an interruption of transcription, replication and/or topoisomerase activity; antiproliferative and antitumor agents
05/2010
05/27/2010US20100130481 Anticonvulsant and anxiolytic methods of using receptor subtype selective agents
05/27/2010CA2740589A1 Compounds that expand hematopoietic stem cells
05/26/2010EP1685135B1 TETRAHYDRO-FURO[3,4-d]DIOXOLE COMPOUNDS AND COMPOSITIONS AND METHOD FOR INHIBITING PLATELET AGGREGATION
05/26/2010EP1562946B1 Novel xanthine derivatives, the production and the use thereof in the form of drugs
05/26/2010CN1993361B Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
05/26/2010CN1953983B 1-heterocyclyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones
05/26/2010CN1649883B Bicyclic 6-alkylidene-penems as lactamases inhibitors
05/26/2010CN1642580B Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
05/26/2010CN101712689A Azepine condensed ring substituted cephalosporin derivative
05/25/2010US7723324 Treating anxiety and insomnia; drugs facilitate the inhibitory action of the neurotransmitter GABA; 2-(6-Methyl-2-p-tolyl-imidazo[1,2-a]pyridin-3-yl)-1-thiophen-2-yl-ethanone for example
05/20/2010WO2010056875A1 Pyridazinones and their use as btk inhibitors
05/20/2010WO2010056631A1 Inhibitors of fatty acid binding protein (fabp)
05/20/2010CA2743299A1 Inhibitors of fatty acid binding protein (fabp)
05/19/2010EP2185555A1 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
05/19/2010EP1682553B1 Thienopyrazoles
05/19/2010EP1180991B1 Gambogic acid derivatives as activators of caspases and inducers of apoptosis
05/19/2010CN101711243A 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
05/18/2010CA2131797C Condensed indole derivatives as 5ht4-receptor antagonists
05/14/2010WO2010054253A1 Triazine derivatives as inhibitors of phosphodiesterases
05/14/2010WO2010053127A1 MODULATOR OF α1GABAA RECEPTOR OR α5GABAA RECEPTOR
05/12/2010EP1663219B1 Use of indole-derived compounds for the preparation of a medicament that can be used to treat diseases related to the splicing process
05/12/2010CN101704828A Melonine class double-indole compound, medicine composition, preparation method and application thereof
05/12/2010CN101161656B Dibenzo tetrathiafulvalene tetracarbonyl imide derivative and preparation method and uses thereof
05/11/2010US7714098 Mono-, oligo- and polythieno[3,2-b]thiophenes
05/11/2010CA2503663C Novel quinoxalinone derivatives
05/06/2010WO2010050778A1 Novel compounds for organic electronic material and organic electronic device using the same
05/06/2010WO2010050468A1 Cephalosporin having catechol group
05/06/2010CA2736953A1 Cepharosporins having a catechol group
05/05/2010EP2181996A1 Aminopiperidine derivatives
05/05/2010CN1938321B Novel compound and organic electronic device using such compound
05/05/2010CN1706839B Material containing non-benzenoid aryl spiro and its synthesis and application
05/04/2010US7709660 Polymethine ether compounds
05/04/2010US7709263 use of the complexes obtained as fluorescent markers, and as relaxation agents for NMR or for NMR imaging; [Eu.(1-4H).H2O]Na
04/2010
04/29/2010WO2010046791A1 Phosphodiestarase inhibitors
04/29/2010WO2010046445A2 Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use
04/29/2010WO2010046013A1 Azaindole derivative
04/29/2010CA2741428A1 Azaindole derivatives
04/29/2010CA2738453A1 Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use
04/29/2010CA2735956A1 Phosphodiestarase inhibitors
04/28/2010EP2178879A2 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof
04/28/2010EP2178878A1 Tetracyclic compounds for the treatment of hepatitis c
04/28/2010EP2178375A1 Pyrazoloý1,5-a¨pyrimidine derivatives
04/28/2010EP1461339B1 Spiroazacyclic compounds as monoamine receptor modulators
04/27/2010US7705177 t-Butyl 1-[9-[1-(tert-butoxycarbonyl)cyclopropyl]-5-oxononyl]-1-cyclopropanecarboxylate; Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, impotence
04/27/2010US7705015 Substituted pyrroline kinase inhibitors
04/27/2010US7704999 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
04/27/2010CA2437524C Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
04/22/2010WO2010044470A1 Π-electron conjugated compound, manufacturing method therefor, and π-electron conjugated polymer obtained using same
04/22/2010WO2010043877A1 Pyrrolobenzodiazepines
04/22/2010WO2010043714A1 Tricyclic nitrogen compounds used as antibacterials
04/22/2010WO2009034546A3 Trans-decahydroisoquinoline derivatives
04/22/2010CA2740713A1 Pyrrolobenzodiazepines
04/21/2010EP1891077B1 Monomers , oligomers and polymers of thieno (3, 4-d) thiazole
04/21/2010CN101696208A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists
04/20/2010US7700591 to prevent or treat inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis
04/20/2010CA2565411C Compounds and methods for inhibiting mitotic progression
04/15/2010WO2010042473A1 Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators
04/15/2010WO2010041194A1 Tricyclic oxazolidinone antibiotic compounds
04/15/2010US20100093785 Diamine derivatives
04/15/2010CA2739373A1 Tricyclic oxazolidinone antibiotic compounds
04/14/2010CN101693722A Polymerisable thieno not 3,2-b thiophenes
04/13/2010US7696354 antibacterial activities against cephem-resistant Pseudomonas aeruginosa which produce beta -lactamase; antibiotic resistance; pharmacokinetics; high water solubility; a halogen atom or the like into an aminothiazole ring on the 7-side chain, a carboxyl group into the end of the oxime group
04/13/2010US7696212 1-[(phenanthridin-6-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-amino-piperidin-1-yl)-xanthine; antiarthritic agents; obesity; antidiabetic agents; osteoporosis; dipeptidylpeptidase-IV (DPP-IV) inhibitors
04/13/2010US7696206 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
04/13/2010CA2430363C Compounds and their uses
04/13/2010CA2425440C Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
04/08/2010DE19820157B4 Neue Verbindungen auf Basis von Polyalkyl-1-oxa-diazaspirodecan-Verbindungen New connections based on polyalkyl-1-oxa-diazaspirodecan connections
04/07/2010EP2170892A2 Imidazopyrazines as protein kinase inhibitors
04/07/2010EP1979351B1 6-phenyl-1h-imidazo[4, 5-c]pyridine-4-carbonitrile derivatives as cathepsin k and s inhibitors
04/07/2010CN101691370A Triazolo[4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists
04/06/2010US7692014 Inhibitors of the HIV integrase enzyme
04/06/2010US7691846 blood coagulation factor (trypsin-like serine protease enzymes) inhibitor; 1-(3-amino-1,2-benzisoxazol-5-yl)-5-{[5-(2-oxo-1-piperidinyl)-2,3-dihydro-1H-indol-1-yl]carbonyl}-1H-pyrazole-3-carboxamide; anticoagulant; cardiovascular thromboembolic disorder transient ischemic attack, stroke, atherosclerosis
04/06/2010US7691842 Tricyclic 6-alkylidene-penems as β-lactamase inhibitors
04/06/2010CA2358505C Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
04/01/2010WO2010036494A1 Active materials for photoelectric devices
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 111